Australia markets open in 5 hours 37 minutes

Opthea Limited (OPT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.9950-0.0150 (-1.49%)
At close: 04:10PM AEDT
Full screen
Previous close1.0100
Open0.9950
Bid0.9450 x 1566800
Ask0.9950 x 380500
Day's range0.9750 - 1.0300
52-week range0.7900 - 1.3950
Volume196,691
Avg. volume341,323
Market cap402.95M
Beta (5Y monthly)0.31
PE ratio (TTM)N/A
EPS (TTM)-0.2320
Earnings date27 Feb 2023 - 03 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend date11 Oct 2004
1y target est1.65
  • GlobeNewswire

    Opthea To Present at SVB Leerink Global Biopharma Conference

    MELBOURNE, Australia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Chief Executive Officer will present at SVB Leerink’s Global Biopharma Conference being held virtually on February 14-16, 2023. Dr. Baldwin’s presentation will take place on Wednesday February 15th at 5:00 pm ET (9:00 am A

  • GlobeNewswire

    Opthea To Present at Sequire Biotechnology Conference

    MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Chief Executive Officer will present at the Sequire Biotechnology Conference being held virtually on February 2, 2023. Dr. Baldwin will present on Thursday, February 2nd at 10:00 am ET (2:00 am AEDT). To access the present

  • GlobeNewswire

    Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD

    MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announce that MST Access will host an “Ask the Expert” conference call with Professor Jason S. Slakter, M.D. on Tuesday 13th December 6:30pm – 7:30pm EST USA (Wednesday 14th December 10:30am – 11:30am AEDT). Prof Slakter is a board certified Retinal and Macular Disease Specia